| |
|
|
|
ENDRA Life Sciences Inc.  
|
|
0.65 -0.11 (-0.14%) |
11-20 16:00 |
|
Open: |
0.798 |
Pre close: |
0.76 |
Target:
|
1.29 
|
|
High: |
0.798 |
Low: |
0.65 |
Resistance:
|
1.10
1.38
|
|
Volume: |
203,607 |
Market Cap: |
5M |
Support:
|
0.65
0.54
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.88
|
MACD |
MACD(12,26):
|
-0.10 |
|
MA(20): |
1.02 |
Signal(12,26,9): |
-0.07 |
|
MA(100): |
1.35 |
Stochastic Oscillator |
%K(14,3):
|
0.76 |
|
MA(250): |
1.67 |
%D(3): |
14.50 |
|
Average Volume(K) |
3-Month: |
8368
|
52-Week |
High:
|
4.21 |
|
10-Days: |
8345 |
Low: |
0.65 |
|
RSI |
RSI(14):
|
18.37 |
Change(%): |
-84.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.523 |
Return on Equity (ttm) |
-2298.6 |
Shares Out. (M) |
7.42 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-240.1 |
Shares Float (M) |
7.19 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.51 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
18.35 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.001 |
Shares Short (K) |
770 |
|
Book Value (p.s.) |
0.190 |
EBITDA (p.s.) |
-1.260 |
P/E |
-0.43 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.42 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-8.58 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.75 |
P/CF |
-0.56 |
|
|
|
|
|
|
